schizandrin b has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Li, H; Li, Z; Su, X; Wang, Y; Zhao, N; Zhuang, W | 1 |
| Jung, TH; Kim, JM; Lee, J; Lee, YM; Park, SM; Ryu, HS | 1 |
2 other study(ies) available for schizandrin b and B16 Melanoma
| Article | Year |
|---|---|
Schisandrin B inhibits α-melanocyte-stimulating hormone-induced melanogenesis in B16F10 cells via downregulation of MAPK and CREB signaling pathways.
Topics: alpha-MSH; Animals; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Cyclooctanes; Down-Regulation; Lignans; MAP Kinase Signaling System; Melanins; Melanoma, Experimental; Mice; Polycyclic Compounds; Signal Transduction | 2021 |
Anti-melanogenic effect of gomisin N from Schisandra chinensis (Turcz.) Baillon (Schisandraceae) in melanoma cells.
Topics: alpha-MSH; Animals; Cyclooctanes; Lignans; Magnetic Resonance Spectroscopy; Melanins; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Phosphorylation; Plant Extracts; Polycyclic Compounds; Proto-Oncogene Proteins c-akt; Schisandra | 2017 |